FAILURE OF PARTIAL HYPOPHYSECTOMY AS DEFINITIVE TREATMENT IN CUSHINGS-DISEASE OWING TO NODULAR CORTICOTROPE HYPERPLASIA - REPORT OF 4 CASES

Citation
Lr. Salgado et al., FAILURE OF PARTIAL HYPOPHYSECTOMY AS DEFINITIVE TREATMENT IN CUSHINGS-DISEASE OWING TO NODULAR CORTICOTROPE HYPERPLASIA - REPORT OF 4 CASES, Endocrine pathology, 6(1), 1995, pp. 57-66
Citations number
36
Categorie Soggetti
Pathology,"Endocrynology & Metabolism
Journal title
ISSN journal
10463976
Volume
6
Issue
1
Year of publication
1995
Pages
57 - 66
Database
ISI
SICI code
1046-3976(1995)6:1<57:FOPHAD>2.0.ZU;2-J
Abstract
Nodular corticotrope hyperplasia is a rare pathology causing Gushing's syndrome owing to a primary pituitary disease or ectopic CRH producti on. In this study, we evaluated the laboratory and pathological findin gs and results of transsphenoidal pituitary surgery in four patients w ith Gushing's disease. Dynamic tests of pituitary-adrenal function (de xamethasone suppression, metyrapone, CRH, and DDAVP tests) were done b efore and after transsphenoidal pituitary surgery. Plasma and total ur inary cortisol, serum 11-deoxycortisol, and plasma ACTH were determine d by RIA. Hormonal dynamic tests and radiologic studies were compatibl e with a pituitary ACTH source. The transsphenoidal surgery revealed t he presence of corticotrope hyperplasia confirmed by immunoperoxidase stain and a preserved reticulum framework in the removed pituitary tis sue of these four patients. The pituitary surgery led to a short perio d of improvement in two of the patients (1 and 4), a 3-yr remission in one patient (patient 2), and no improvement in one (patient 3). We co nclude that although our patients appear to have inadequate suppressio n with high-dose dexamethasone, there is no way to diagnose this patho logy presurgically, and that total hypophysectomy, bilateral adrenalec tomy, and irradiation are the only alternatives for definitive treatme nt. A CRH-secreting ectopic tumor could not be found in our patients e ither before or after surgery in the follow-up period.